Daxor News

Investor's Confidence in German Economy Is Growing -- Market Talk

0855 GMT - Investors' confidence in the German economy has been increasing, even if the data is only now reflecting it, CMC Markets analysts say in a research note. Last week's impressive rally pushed

WSJMay 13 04:56 ET

New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

Data Presented at the American College of Cardiology Scientific Sessions; Research Letter Published in the Prestigious American Heart Journal Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation

GlobeNewswireApr 16 08:00 ET

Daxor's Promising Growth and Innovation Outlook Merit a Buy Rating

TipRanksApr 15 05:17 ET

Express News | Daxor Corp : Ascendiant Capital Markets Raises Target Price to $24.5 From $24

Moomoo 24/7Apr 14 23:08 ET

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

450-Bed Hospital Purchases BVA-100 Blood Volume Analyzer to Launch Heart Failure Program Oak Ridge, TN, April 10, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood

GlobeNewswireApr 10 08:00 ET

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

Oak Ridge, TN, April 01, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American Col

GlobeNewswireApr 1 08:00 ET

Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 28 10:38 ET

Daxor(DXR.US) Officer Buys US$6,525 in Common Stock

$Daxor(DXR.US)$ Officer Michel Robert J purchased 750 shares of Common Stock on Mar 27, 2024 at an average price of $8.7 for a total value of $6,525.Source: Announcement What is statement of changes i

moomoo NewsMar 27 14:20 ET

Analysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL) and Daxor (DXR)

TipRanksMar 27 07:30 ET

Earnings Call Summary | Daxor(DXR.US) Q4 2023 Earnings Conference

The following is a summary of the Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript:Financial Performance:Daxor's net assets increased by 17.4% in 2023, reaching $34,10,384, equivalent to $7.08

moomoo AIMar 25 20:44 ET · Conference Call

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript

Earnings Call TranscriptsMar 25 20:05 ET

Daxor Corporation Acquires Volumex and Megatope From Its Existing Supplier Along With Glofil to Enhance Existing Suite of Diagnostics

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, announces today it

GlobeNewswireMar 25 08:00 ET

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

Oak Ridge, TN, March 22, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, announces an investor call to be held on Monday, March 25, 2024, at 4:00 p.m.

GlobeNewswireMar 22 08:00 ET

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholder

GlobeNewswireMar 18 14:18 ET

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Strong Start to 2024 with Unaudited Revenue Climbing 229.1% in First Two Months of 2024 YoY Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in bl

GlobeNewswireMar 18 14:18 ET

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base

Oak Ridge, TN, March 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today announces the expansion of blood volume analysis (BVA) in three new

GlobeNewswireMar 11 08:00 ET

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients

Only Daxor's BVA Diagnostic Was Shown to Accurately Reflect Blood Volume Compared to Inferior Surrogates Oak Ridge, TN, March 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood

GlobeNewswireMar 8 08:00 ET

Daxor(DXR.US) Director Buys US$7,210 in Common Stocks

$Daxor(DXR.US)$ Director Feuer Edward purchased 1,000 shares of Common Stocks on Mar 4, 2024 at an average price of $7.21 for a total value of $7,210.Source: Announcement What is statement of changes

moomoo NewsMar 6 17:02 ET

Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference

Oak Ridge, TN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Technology an

GlobeNewswireFeb 26 08:00 ET

Daxor Announces Two Significant New Customer Transactions With The Co's BVA-100 In January; No Financial Terms Disclosed

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today announces two significant new customer transactions with Daxor's BVA-100 (Blood Volume Analyzer) in Janua

BenzingaFeb 12 08:15 ET